Director – Cardiometabolic Health Global Medical Affairs, CV Outcomes/NILEX HEOR team

Eli Lilly and Company•Indianapolis, IN

1d•$165,000 - $290,400

About The Position

At Lilly, we unite caring with discovery to make life better for people around the world. We are a global healthcare leader headquartered in Indianapolis, Indiana. Our employees around the world work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to our communities through philanthropy and volunteerism. We give our best effort to our work, and we put people first. We’re looking for people who are determined to make life better for people around the world. Job Description Director – Cardiometabolic Health Global Medical Affairs, CV Outcomes/NILEX HEOR team Purpose: The need for high quality health economic and outcomes research (HEOR) and real-world evidence (RWE) to support drug development through the lifecycle, health technology assessment/access decisions, product differentiation, and clinical decision making continues to increase. The purpose of the Cardiometabolic Health (CMH) Global Medical Affairs, Cardiovascular (CV) Outcomes/New Indication Line Extension (NILEX) HEOR team is to accelerate equitable patient access and transform healthcare delivery through the execution and communication of bold, high impact science. The Director provides strategic leadership to therapeutic area (TA) portfolio under global medical affairs leadership, ensuring integration and execution of Health Outcomes (HO) and Real World Evidence (RWE) strategy and implementation with relevant business and alliance partners. The Senior Director will lead and develop research and capabilities to provide support for all prioritized products in the portfolio. This individual will be responsible for strategy and implementation of HEOR projects and studies throughout Phases 1-4 of development. They will also work closely with the US Customer Engagement team and the HEOR International team to coordinate and transition work needed for geographic needs after product launch.

Requirements

Doctoral (e.g. PhD, DrPH, ScD, MD), Master’s, or PharmD degree
10+ years of strong HEOR experience in creating, executing, and delivering patient measurement/ clinical outcomes assessment (COA) strategies and other healthcare outcomes strategies

Nice To Haves

Cardiovascular/Cardiometabolic Health expertise is strongly preferred
Therapeutic expertise in research discipline related to health outcomes
Proven ability to manage a large complex research portfolio
Ability to inspire and set strategic direction
Demonstrated ability to drive research agendas to completion and dissemination
Ability to think and act globally with a customer focus and a solution orientation
Strong comprehension and communication skills including the ability to translate and disseminate complex scientific information in a clear and concise manner
Strong understanding of US and global health care systems and environment
Relevant disease state expertise in the field of Therapeutic Area
Proven ability to influence across the organization

Responsibilities

Establish priorities for HEOR activities in alignment with molecule teams and TA Governance teams.
Provide input into the TA portfolio strategy to the Business Unit Accountable for design and delivery of platform and disease HO/RWE strategy
Ensure that business plans are appropriate and aligned geographically based on the therapeutic HO/RWE research strategy
Ensure business plans reflect geographic needs and align with global strategy.
Engage therapeutic area leaders and collaborate with geographic leaders to drive strategy and deliver bold, high impact research
Contribute to clinical trial and HO/RWE protocols, data analysis and manuscripts
Provide strategic input for product development teams for completion and updating of the Target Product Profile/ Draft Launch Label.
Accountable for major HO/RWE study design elements for key studies to support brand/product
Facilitate strong collaboration with medical, PRA, regulatory, LVA, LCCI, etc. to optimally support the brand/molecule
Work closely with CMH GMA team leaders to ensure on-strategy, on-time, on-budget delivery of all research deliverables in support of the Cardiometabolic portfolio
Provide scientific leadership and coaching regarding strategy, tactics and teamwork
Communicate and collaborate with functional partners e.g., IDS, statistics, scientific communications
Develop and implement HO/RWE strategy in line with global medical strategy
Ensure quality and compliance of research execution and deliverables

Benefits

Full-time equivalent employees also will be eligible for a company bonus (depending, in part, on company and individual performance). In addition, Lilly offers a comprehensive benefit program to eligible employees, including eligibility to participate in a company-sponsored 401(k); pension; vacation benefits; eligibility for medical, dental, vision and prescription drug benefits; flexible benefits (e.g., healthcare and/or dependent day care flexible spending accounts); life insurance and death benefits; certain time off and leave of absence benefits; and well-being benefits (e.g., employee assistance program, fitness benefits, and employee clubs and activities).

Stand Out From the Crowd

Upload your resume and get instant feedback on how well it matches this job.

Upload and Match Resume